サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1179503

3D細胞培養市場：製品別、用途別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

3D Cell Culture Market By Product, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日: | 発行: Allied Market Research | ページ情報: 英文 244 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
3D細胞培養市場：製品別、用途別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年
出版日: 2022年09月01日
発行: Allied Market Research
ページ情報: 英文 244 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

3D細胞培養は、人工的に作られた環境で細胞が成長することができる体外技術です。

これらの環境は、本来の組織の構造と機能に酷似しています。3D細胞培養技術は、生体内の環境と同じように3次元の環境と相互作用することによって、細胞の分化、増殖、移動を刺激するのに役立ちます。3D細胞培養は、生体内組織の構造、活性、微小環境を模倣できるため、この技術は、薬剤スクリーニング、再生医療、幹細胞治療、がん研究、細胞生物学の分野でさまざまな応用が可能です。3次元培養では、細胞外マトリックスがサイトカインや栄養因子を分泌し、生体内環境と同じように直接接触して細胞間のコミュニケーションを可能にします。これらの因子が2次元環境で変化すると、細胞間コミュニケーションに大きな影響を与え、その結果、細胞の形態や増殖が変化する可能性があります。2次元培養では3次元培養のような構造や複雑な細胞マトリクスを再現できないため、この技術はヘルスケア研究分野で人気を集めています。さらに、3D細胞培養は、効率を改善した結果を提供し、研究開発プロセス全体のコストを削減することができます。

3D細胞培養市場は、製品によって、足場ベースのプラットフォーム、足場なしのプラットフォーム、ゲル、バイオリアクター、マイクロチップ、サービスに分類されます。足場ベースのプラットフォームは、細胞が容易に3D成長を付与することができる表面を提供することにより、細胞培養手順を変更するために使用されます。足場は、様々な材料や構造の選択が可能であるため、創薬や細胞増殖に利用されています。また、足場はイメージングが容易であり、アッセイプロトコルが簡便であるという利点もあります。さらに、足場の機械的および生化学的特性は、アプリケーションの必要性に応じて容易に変更することができます。したがって、3D細胞培養を作成するための足場ベースのプラットフォームに対する高い需要があるため、このセグメントは予測期間を通じて製品セグメントを支配すると予想されます。しかしながら、足場ベースのプラットフォームは、被験物質を吸着し、分析のための下流エンドポイントを制限し、異なる生物学的物質を導入することができるため、セグメントの成長を阻害する可能性があります。

3D細胞培養市場は、用途に基づいて、がん研究、幹細胞研究、創薬、再生医療に区分されます。がん研究分野は、分析期間中に最も大きく成長する分野と予想されます。これには、細胞増殖や形態の変更が容易であること、現実的な薬物反応を明らかにすること、表現型の異質性を捉えること、遺伝子発現や細胞挙動における実験的操作を可能にすること、腫瘍微小環境を表現することなどが含まれます。3D細胞培養の利点を早期に活用する前臨床研究は、がん生物学の理解を決定的に向上させることができます。これには、貧弱な薬剤候補の排除や、以前は2次元培養ではアクセスできなかった生理学的に関連するターゲットの同定が含まれます。これは、このセグメントの成長に大きく貢献する可能性があります。

エンドユーザーに基づき、世界の3D細胞培養市場は、バイオテクノロジー＆製薬会社、契約研究機関、学術機関に区分されます。分析期間を通して、学術機関セグメントがエンドユーザー部門で支配的な地位を占めました。この成長は、様々なヘルスケアアプリケーションのための3D細胞培養の需要の増加により、研究機関や臨床研究所と複数の企業間の協力が増加したことに起因しています。例えば、Procter &Gamble（P&G）と英国のDurham Universityは、老化プロセスをin-vitroで研究するために、組織模倣型2Dプラットフォームを使って3D皮膚代替物を作るために共同研究を行っています。さらに、多くの学術機関が、さまざまな病状を治療するための新しいアプローチを開発するために、3D培養モデルの研究開発活動に注力しています。このような学術機関や大学における研究活動の急増が、分析期間中の同分野の成長を促進すると予測されます。

北米は、再生医療や創薬開発のために研究機関や臨床研究所と協力して3D培養技術を使用する製薬会社やバイオテクノロジー会社が複数存在するため、予測期間中も優位性を維持すると予想されます。さらに、臓器移植の需要の増加や、技術的に高度なソリューションに焦点を当てた研究開発活動の活発化が、同地域における3D細胞培養の採用を促進すると予測されます。また、がんの発生件数の急増により、政府はがん分野の研究開発に対する資金提供や助成金を増やしており、3D細胞培養市場の成長にプラスの影響を与える可能性があります。さらに、バイオテクノロジー企業や製薬企業の戦略的拡大により、先進的な製品が発売されており、今後数年間で市場の成長を増大させると予想されます。

利害関係者にとっての主なメリット

当レポートは、2021年から2031年までの3D細胞培養市場分析の市場セグメント、現在の動向、推定、力学を定量的に分析し、3D細胞培養市場の優勢な機会を特定します。

市場調査は、主要促進要因、市場抑制要因、機会に関する情報とともに提供されます。

ポーターのファイブフォース分析は、利害関係者が利益志向のビジネス決定を行い、サプライヤーとバイヤーのネットワークを強化できるよう、バイヤーとサプライヤーの効力を強調します。

3D細胞培養市場のセグメンテーションの詳細な分析は、一般的な市場機会を決定することを支援します。

各地域の主要国は、世界市場に対する収益貢献度に応じてマッピングされています。

市場プレイヤーのポジショニングは、ベンチマークを容易にし、市場プレイヤーの現在の位置づけを明確に理解することができます。

当レポートでは、地域および世界の3D細胞培養の市場動向、主要企業、市場セグメント、応用分野、市場成長戦略に関する分析を掲載しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
  • ポーターのファイブフォース分析
  • 主要企業のポジショニング
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • COVID-19 影響分析

第4章 3D細胞培養市場：製品別

  • 概要
    • 市場規模および予測
  • 足場ベースのプラットフォーム
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別分析
    • 足場型プラットフォームの3D細胞培養市場：マクロスケール別
    • 足場型プラットフォームの3D細胞培養市場：マイクロスケール別
    • 足場型プラットフォームの3D細胞培養市場：ナノスケール別
    • 足場ベースの3D細胞培養プラットフォーム市場：固体足場別
  • 足場不要プラットフォーム
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別分析
  • ゲル
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • バイオリアクター
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • マイクロチップ
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • サービス
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別

第5章 3D細胞培養市場：用途別

  • 概要
    • 市場規模・予測
  • がん研究分野
    • 主な市場動向、成長要因と機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 幹細胞調査
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 創薬
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 再生医療
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別

第6章 3D細胞培養市場：エンドユーザー別

  • 概要
    • 市場規模・予測
  • バイオテクノロジー企業、製薬企業
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 調査受託機関
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 学術機関
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別

第7章 3D細胞培養市場：地域別

  • 概要
    • 市場規模・予測
  • 北米
    • 主な動向と機会
    • 北米市場規模・予測：製品別
    • 北米市場規模・予測：アプリケーション別
    • 北米市場規模・予測：エンドユーザー別
    • 北米市場規模・予測：国別
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 主な動向と機会
    • 欧州市場規模・予測：製品別
    • 欧州市場規模・予測：アプリケーション別
    • 欧州市場規模・予測：エンドユーザー別
    • 欧州市場規模・予測：国別
      • ドイツ
      • フランス
      • 英国
      • その他欧州地域
  • アジア太平洋地域
    • 主な動向と機会
    • アジア太平洋地域の市場規模・予測：製品別
    • アジア太平洋地域の市場規模・予測：アプリケーション別
    • アジア太平洋地域の市場規模・予測：エンドユーザー別
    • アジア太平洋地域の市場規模・予測：国別
      • 日本
      • 中国
      • インド
      • オーストラリア
      • その他アジア太平洋地域
  • LAMEA
    • 主な動向と機会
    • LAMEAの市場規模・予測：製品別
    • LAMEAの市場規模・予測：アプリケーション別
    • LAMEAの市場規模・予測：エンドユーザー別
    • LAMEAの市場規模・予測：国別
      • ブラジル
      • サウジアラビア
      • 南アフリカ共和国
      • LAMEAの残りの地域

第8章 企業情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合のヒートマップ
  • 主な発展

第9章 企業プロファイル

  • 3d Biotek LLC
  • Advanced Biomatrix, Inc.
  • Avantor, Inc.
  • Becton, Dickinson And Company
  • Corning Incorporated
  • Insphero AG
  • Lonza Group LTD.
  • Merck & Co., Inc.
  • Synthecon, Incorporated
  • Thermo Fisher Scientific Inc.
図表

LIST OF TABLES

  • TABLE 1. GLOBAL 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 2. 3D CELL CULTURE MARKET SIZE, FOR SCAFFOLD BASED PLATFORMS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. 3D CELL CULTURE MARKET FOR SCAFFOLD BASED PLATFORMS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. GLOBAL SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET, BY MACRO-SCALE, 2021-2031 ($MILLION)
  • TABLE 5. GLOBAL SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET, BY MICRO-SCALE, 2021-2031 ($MILLION)
  • TABLE 6. GLOBAL SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET, BY NANO-SCALE, 2021-2031 ($MILLION)
  • TABLE 7. GLOBAL SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET, BY SOLID SCAFFOLDS, 2021-2031 ($MILLION)
  • TABLE 8. 3D CELL CULTURE MARKET SIZE, FOR SCAFFOLD FREE PLATFORMS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 9. 3D CELL CULTURE MARKET FOR SCAFFOLD FREE PLATFORMS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 10. 3D CELL CULTURE MARKET SIZE, FOR GELS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 11. 3D CELL CULTURE MARKET FOR GELS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 12. 3D CELL CULTURE MARKET SIZE, FOR BIOREACTORS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 13. 3D CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 14. 3D CELL CULTURE MARKET SIZE, FOR MICROCHIPS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 15. 3D CELL CULTURE MARKET FOR MICROCHIPS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 16. 3D CELL CULTURE MARKET SIZE, FOR SERVICES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 17. 3D CELL CULTURE MARKET FOR SERVICES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 18. GLOBAL 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 19. 3D CELL CULTURE MARKET SIZE, FOR CANCER RESEARCH, BY REGION, 2021-2031 ($MILLION)
  • TABLE 20. 3D CELL CULTURE MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 21. 3D CELL CULTURE MARKET SIZE, FOR STEM CELL RESEARCH, BY REGION, 2021-2031 ($MILLION)
  • TABLE 22. 3D CELL CULTURE MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 23. 3D CELL CULTURE MARKET SIZE, FOR DRUG DISCOVERY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 24. 3D CELL CULTURE MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 25. 3D CELL CULTURE MARKET SIZE, FOR REGENERATIVE MEDICINE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 26. 3D CELL CULTURE MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 27. GLOBAL 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 28. 3D CELL CULTURE MARKET SIZE, FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 29. 3D CELL CULTURE MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 30. 3D CELL CULTURE MARKET SIZE, FOR CONTRACT RESEARCH LABORATORIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 31. 3D CELL CULTURE MARKET FOR CONTRACT RESEARCH LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 32. 3D CELL CULTURE MARKET SIZE, FOR ACADEMIC INSTITUTES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 33. 3D CELL CULTURE MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 34. 3D CELL CULTURE MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 35. NORTH AMERICA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 36. NORTH AMERICA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 37. NORTH AMERICA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 38. NORTH AMERICA 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 39. U.S. 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 40. U.S. 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 41. U.S. 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 42. CANADA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 43. CANADA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 44. CANADA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 45. MEXICO 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 46. MEXICO 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 47. MEXICO 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 48. EUROPE 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 49. EUROPE 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 50. EUROPE 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 51. EUROPE 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 52. GERMANY 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 53. GERMANY 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 54. GERMANY 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 55. FRANCE 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 56. FRANCE 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 57. FRANCE 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 58. UK 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 59. UK 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 60. UK 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 61. REST OF EUROPE 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 62. REST OF EUROPE 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 63. REST OF EUROPE 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 64. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 65. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 66. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 67. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 68. JAPAN 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 69. JAPAN 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 70. JAPAN 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 71. CHINA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 72. CHINA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 73. CHINA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 74. INDIA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 75. INDIA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 76. INDIA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 77. AUSTRALIA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 78. AUSTRALIA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 79. AUSTRALIA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 80. REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 81. REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 82. REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 83. LAMEA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 84. LAMEA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 85. LAMEA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 86. LAMEA 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 87. BRAZIL 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 88. BRAZIL 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 89. BRAZIL 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 90. SAUDI ARABIA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 91. SAUDI ARABIA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 92. SAUDI ARABIA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 93. SOUTH AFRICA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 94. SOUTH AFRICA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 95. SOUTH AFRICA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 96. REST OF LAMEA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 97. REST OF LAMEA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 98. REST OF LAMEA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 99.3D BIOTEK LLC: COMPANY SNAPSHOT
  • TABLE 100.3D BIOTEK LLC: OPERATING SEGMENTS
  • TABLE 101.3D BIOTEK LLC: PRODUCT PORTFOLIO
  • TABLE 102.3D BIOTEK LLC: NET SALES,
  • TABLE 103.3D BIOTEK LLC: KEY STRATERGIES
  • TABLE 104.ADVANCED BIOMATRIX, INC.: COMPANY SNAPSHOT
  • TABLE 105.ADVANCED BIOMATRIX, INC.: OPERATING SEGMENTS
  • TABLE 106.ADVANCED BIOMATRIX, INC.: PRODUCT PORTFOLIO
  • TABLE 107.ADVANCED BIOMATRIX, INC.: NET SALES,
  • TABLE 108.ADVANCED BIOMATRIX, INC.: KEY STRATERGIES
  • TABLE 109.AVANTOR, INC.: COMPANY SNAPSHOT
  • TABLE 110.AVANTOR, INC.: OPERATING SEGMENTS
  • TABLE 111.AVANTOR, INC.: PRODUCT PORTFOLIO
  • TABLE 112.AVANTOR, INC.: NET SALES,
  • TABLE 113.AVANTOR, INC.: KEY STRATERGIES
  • TABLE 114.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 115.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
  • TABLE 116.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 117.BECTON, DICKINSON AND COMPANY: NET SALES,
  • TABLE 118.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
  • TABLE 119.CORNING INCORPORATED: COMPANY SNAPSHOT
  • TABLE 120.CORNING INCORPORATED: OPERATING SEGMENTS
  • TABLE 121.CORNING INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 122.CORNING INCORPORATED: NET SALES,
  • TABLE 123.CORNING INCORPORATED: KEY STRATERGIES
  • TABLE 124.INSPHERO AG: COMPANY SNAPSHOT
  • TABLE 125.INSPHERO AG: OPERATING SEGMENTS
  • TABLE 126.INSPHERO AG: PRODUCT PORTFOLIO
  • TABLE 127.INSPHERO AG: NET SALES,
  • TABLE 128.INSPHERO AG: KEY STRATERGIES
  • TABLE 129.LONZA GROUP LTD.: COMPANY SNAPSHOT
  • TABLE 130.LONZA GROUP LTD.: OPERATING SEGMENTS
  • TABLE 131.LONZA GROUP LTD.: PRODUCT PORTFOLIO
  • TABLE 132.LONZA GROUP LTD.: NET SALES,
  • TABLE 133.LONZA GROUP LTD.: KEY STRATERGIES
  • TABLE 134.MERCK & CO., INC.: COMPANY SNAPSHOT
  • TABLE 135.MERCK & CO., INC.: OPERATING SEGMENTS
  • TABLE 136.MERCK & CO., INC.: PRODUCT PORTFOLIO
  • TABLE 137.MERCK & CO., INC.: NET SALES,
  • TABLE 138.MERCK & CO., INC.: KEY STRATERGIES
  • TABLE 139.SYNTHECON, INCORPORATED: COMPANY SNAPSHOT
  • TABLE 140.SYNTHECON, INCORPORATED: OPERATING SEGMENTS
  • TABLE 141.SYNTHECON, INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 142.SYNTHECON, INCORPORATED: NET SALES,
  • TABLE 143.SYNTHECON, INCORPORATED: KEY STRATERGIES
  • TABLE 144.THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 145.THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
  • TABLE 146.THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 147.THERMO FISHER SCIENTIFIC INC.: NET SALES,
  • TABLE 148.THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.3D CELL CULTURE MARKET SEGMENTATION
  • FIGURE 2.3D CELL CULTURE MARKET,2021-2031
  • FIGURE 3.3D CELL CULTURE MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.3D CELL CULTURE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.3D CELL CULTURE MARKET,BY PRODUCT,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF SCAFFOLD FREE PLATFORMS 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF GELS 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF BIOREACTORS 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF MICROCHIPS 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF SERVICES 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 19.3D CELL CULTURE MARKET,BY APPLICATION,2021(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF CANCER RESEARCH 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF STEM CELL RESEARCH 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF REGENERATIVE MEDICINE 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 24.3D CELL CULTURE MARKET,BY END USER,2021(%)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 26.COMPARATIVE SHARE ANALYSIS OF CONTRACT RESEARCH LABORATORIES 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF ACADEMIC INSTITUTES 3D CELL CULTURE MARKET,2021-2031(%)
  • FIGURE 28.3D CELL CULTURE MARKET BY REGION,2021
  • FIGURE 29.U.S. 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 30.CANADA 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 31.MEXICO 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 32.GERMANY 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 33.FRANCE 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 34.UK 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 35.REST OF EUROPE 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 36.JAPAN 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 37.CHINA 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 38.INDIA 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 39.AUSTRALIA 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 40.REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 41.BRAZIL 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 42.SAUDI ARABIA 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 43.SOUTH AFRICA 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 44.REST OF LAMEA 3D CELL CULTURE MARKET,2021-2031($MILLION)
  • FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 49.COMPETITIVE DASHBOARD
  • FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 51.3D BIOTEK LLC.: NET SALES ,($MILLION)
  • FIGURE 52.ADVANCED BIOMATRIX, INC..: NET SALES ,($MILLION)
  • FIGURE 53.AVANTOR, INC..: NET SALES ,($MILLION)
  • FIGURE 54.BECTON, DICKINSON AND COMPANY.: NET SALES ,($MILLION)
  • FIGURE 55.CORNING INCORPORATED.: NET SALES ,($MILLION)
  • FIGURE 56.INSPHERO AG.: NET SALES ,($MILLION)
  • FIGURE 57.LONZA GROUP LTD..: NET SALES ,($MILLION)
  • FIGURE 58.MERCK & CO., INC..: NET SALES ,($MILLION)
  • FIGURE 59.SYNTHECON, INCORPORATED.: NET SALES ,($MILLION)
  • FIGURE 60.THERMO FISHER SCIENTIFIC INC..: NET SALES ,($MILLION)
目次
Product Code: A01155

A 3D cell culture is an in-vitro technique wherein the cells can grow in an artificially created environment. These environments closely resemble the architecture and functioning of the native tissue. 3D cell culture technique helps stimulate cell differentiation, proliferation, and migration by interacting with their three-dimensional surroundings as they would in the in-vivo environment. As 3D cell cultures can mimic the structure, activity, and microenvironment of the in-vivo tissues, this technique has varied applications in the fields of drug screening, regenerative medicine, stem cell therapies, cancer research and cell biology. The extracellular matrix in 3D cell cultures enables cell-cell communication by direct contact as in in-vivo environment by secreting cytokines and trophic factors. These factors are changed in a 2D environment that can significantly affect the cell-cell communication, which in turn can alter the cell morphology and proliferation. As 2D cultures cannot recapitulate the architecture and complex cellular matrices as in 3D cultures, this technique is gaining popularity in healthcare research sector. In addition, 3D cell cultures can provide results with improved efficiency and reduce the cost of overall R&D process. 

Based on product, the 3D cell culture market can be categorized into scaffold-based platforms, scaffold-free platforms, gels, bioreactors, microchips, and services. Scaffold-based platforms are used to alter the cell culture procedure by providing a surface on which the cells can easily impart 3D growth. Scaffolds are used in drug discovery and cell expansion, owing to the availability of a variety of materials and structural choices. In addition, there are other advantages related to the use of scaffold-based platforms such as ease of imaging and simple assay protocol. Moreover, the mechanical and biochemical properties of the scaffold can easily be modified as per the need of the application. Thus, this segment is expected to dominate the product segment throughout the forecast period as there is a high demand for scaffold-based platforms for creating 3D cell cultures. Nevertheless, scaffold-based platforms can adsorb test compounds, limit downstream endpoints for analysis, and introduce different biological substances, thereby obstructing the segment growth.

Based on application, the 3D cell culture market is segmented into cancer research, stem cell research, drug discovery, and regenerative medicine. Cancer research segment is anticipated to be the largest growing segment over the analysis period. This is majorly attributed to the advantages offered by 3D cell culture in cancer research, these include ease of altering cell proliferation and morphology, revealing realistic drug response, capturing phenotypic heterogeneity, allowing experimental manipulation in gene expression & cell behavior and representing the tumor microenvironment. Preclinical studies that utilize the benefits of 3D cell culture early on can critically improvise the understanding of cancer biology. These include elimination of poor drug candidates and identification of physiologically relevant targets that were previously inaccessible in 2D cultures. This can largely contribute toward the segment growth.

Based on end user, the global 3D cell culture market is segmented into biotechnology & pharmaceutical companies, contract research laboratories, and academic institutes. The academic institutes segment held a dominant position in the end user segment throughout the analysis period. This growth is due to rise in collaborations between several companies with research institutes and clinical laboratories owing to the rise in demand of 3D cell cultures for various healthcare applications. For instance, Procter & Gamble (P&G) and Durham University based in the UK have collaborated for engineering 3D skin substitutes with the help of tissue-mimetic 2D platforms for studying the process of ageing in-vitro. In addition, many academic institutes have focused their R&D activities toward 3D culture models for developing novel approaches for treating different medical conditions. This surge in research activities across academic institutes and universities is predicted to propel the growth of the segment over the analysis period.

North America is expected to maintain its dominance during the forecast period due to the presence of several pharmaceutical and biotechnology companies that use 3D culture technology in collaboration with research institutes and clinical laboratories for developing regenerative medicines and drug discovery & development. Furthermore, rise in demand for organ transplantation and upsurge in R&D activities focused on technologically advanced solutions is predicted to fuel the adoption of 3D cell culture practices in the region. In addition, surge in incidences of cancer has led the government to increase the funding and grants for R&D in the field of cancer, which may have a positive impact on the 3D cell culture market growth. Moreover, the strategic expansion of biotechnological and pharmaceutical companies has led to launch of advanced products, which are expected to augment the market growth in coming years.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the 3d cell culture market analysis from 2021 to 2031 to identify the prevailing 3d cell culture market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the 3d cell culture market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global 3d cell culture market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Scaffold Free Platforms
  • Gels
  • Bioreactors
  • Microchips
  • Services
  • Scaffold Based Platforms
    • Macro-scale
    • Micro-scale
    • Nano-scale
    • Solid Scaffolds

By Application

  • Cancer Research
  • Stem Cell Research
  • Drug Discovery
  • Regenerative medicine

By End User

  • Biotechnology and Pharmaceutical Companies
  • Contract Research Laboratories
  • Academic Institutes

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe
  • Asia-Pacific
    • Australia
    • Rest of Asia-Pacific
    • Japan
    • China
    • India
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • 3d Biotek LLC
    • Advanced Biomatrix, Inc.
    • Avantor, Inc.
    • Becton, Dickinson And Company
    • Corning Incorporated
    • Insphero AG
    • Lonza Group LTD.
    • Merck & Co., Inc.
    • Synthecon, Incorporated
    • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: 3D CELL CULTURE MARKET, BY PRODUCT

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Scaffold Based Platforms
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
    • 4.2.4 Scaffold Based Platforms 3D Cell Culture Market by Macro-scale
    • 4.2.5 Scaffold Based Platforms 3D Cell Culture Market by Micro-scale
    • 4.2.6 Scaffold Based Platforms 3D Cell Culture Market by Nano-scale
    • 4.2.7 Scaffold Based Platforms 3D Cell Culture Market by Solid Scaffolds
  • 4.3 Scaffold Free Platforms
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Gels
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country
  • 4.5 Bioreactors
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market analysis by country
  • 4.6 Microchips
    • 4.6.1 Key market trends, growth factors and opportunities
    • 4.6.2 Market size and forecast, by region
    • 4.6.3 Market analysis by country
  • 4.7 Services
    • 4.7.1 Key market trends, growth factors and opportunities
    • 4.7.2 Market size and forecast, by region
    • 4.7.3 Market analysis by country

CHAPTER 5: 3D CELL CULTURE MARKET, BY APPLICATION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Cancer Research
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Stem Cell Research
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Drug Discovery
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Regenerative medicine
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country

CHAPTER 6: 3D CELL CULTURE MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Biotechnology and Pharmaceutical Companies
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Contract Research Laboratories
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Academic Institutes
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country

CHAPTER 7: 3D CELL CULTURE MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Product
    • 7.2.3 North America Market size and forecast, by Application
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Product
      • 7.2.5.1.2 Market size and forecast, by Application
      • 7.2.5.1.3 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Product
      • 7.2.5.2.2 Market size and forecast, by Application
      • 7.2.5.2.3 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Product
      • 7.2.5.3.2 Market size and forecast, by Application
      • 7.2.5.3.3 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Product
    • 7.3.3 Europe Market size and forecast, by Application
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Product
      • 7.3.5.1.2 Market size and forecast, by Application
      • 7.3.5.1.3 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Product
      • 7.3.5.2.2 Market size and forecast, by Application
      • 7.3.5.2.3 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Market size and forecast, by Product
      • 7.3.5.3.2 Market size and forecast, by Application
      • 7.3.5.3.3 Market size and forecast, by End User
      • 7.3.5.4 Rest of Europe
      • 7.3.5.4.1 Market size and forecast, by Product
      • 7.3.5.4.2 Market size and forecast, by Application
      • 7.3.5.4.3 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Product
    • 7.4.3 Asia-Pacific Market size and forecast, by Application
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Market size and forecast, by Product
      • 7.4.5.1.2 Market size and forecast, by Application
      • 7.4.5.1.3 Market size and forecast, by End User
      • 7.4.5.2 China
      • 7.4.5.2.1 Market size and forecast, by Product
      • 7.4.5.2.2 Market size and forecast, by Application
      • 7.4.5.2.3 Market size and forecast, by End User
      • 7.4.5.3 India
      • 7.4.5.3.1 Market size and forecast, by Product
      • 7.4.5.3.2 Market size and forecast, by Application
      • 7.4.5.3.3 Market size and forecast, by End User
      • 7.4.5.4 Australia
      • 7.4.5.4.1 Market size and forecast, by Product
      • 7.4.5.4.2 Market size and forecast, by Application
      • 7.4.5.4.3 Market size and forecast, by End User
      • 7.4.5.5 Rest of Asia-Pacific
      • 7.4.5.5.1 Market size and forecast, by Product
      • 7.4.5.5.2 Market size and forecast, by Application
      • 7.4.5.5.3 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Product
    • 7.5.3 LAMEA Market size and forecast, by Application
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Product
      • 7.5.5.1.2 Market size and forecast, by Application
      • 7.5.5.1.3 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Product
      • 7.5.5.2.2 Market size and forecast, by Application
      • 7.5.5.2.3 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Product
      • 7.5.5.3.2 Market size and forecast, by Application
      • 7.5.5.3.3 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Product
      • 7.5.5.4.2 Market size and forecast, by Application
      • 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 3d Biotek LLC
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Advanced Biomatrix, Inc.
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Avantor, Inc.
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Becton, Dickinson And Company
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Corning Incorporated
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Insphero AG
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Lonza Group LTD.
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Merck & Co., Inc.
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Synthecon, Incorporated
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Thermo Fisher Scientific Inc.
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments